Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
3 hedge funds and large institutions have $1.24M invested in Abeona Therapeutics Inc Warrant in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
37% less capital invested
Capital invested by funds: $1.96M → $1.24M (-$716K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$417 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $1.03M | – | – | – |
|
|
SFM
2
Soros Fund Management
New York
| $213K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | +$417 | +525 | +67% |
|
ABEOW Hedge Fund Activity: Q1 2016 in Review
3 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q1 2016, worth a combined $1.24M — down 37% from $1.96M a quarter earlier.
Fund positioning in ABEOW was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $417.
- 3 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $1.24M of Abeona Therapeutics Inc Warrant stock for Q1 2016, down 37% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q1 2016 and 0 closed out.
- The largest Abeona Therapeutics Inc Warrant buyer in Q1 2016 was UBS Group, an estimated $417 added.
Based on aggregated 13F filings for Q1 2016.